NCT05445726View on ClinicalTrials.gov

ECG Validation Study

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

141

Participants

Timeline

Start Date

May 19, 2022

Primary Completion Date

September 2, 2022

Study Completion Date

November 1, 2023

Conditions
Atrial Fibrillation
Interventions
DEVICE

CPM Device

CPM device used in tangent with reference ECG for validation

Trial Locations (1)

85018

Hope Research Institute, Phoenix

Sponsors

Collaborators (1)

Hope Research Institute
All Listed Sponsors
collaborator

Hope Research Institute

UNKNOWN

lead

Analog Device, Inc.

OTHER